Veracyte (VCYT) Other Accumulated Expenses (2012 - 2025)

Veracyte has disclosed Other Accumulated Expenses across 12 years of filings, most recently posting $7000.0 for Q1 2025.

• Other Accumulated Expenses for Q1 2025 came in at $7000.0, down 92.13% year-over-year; the trailing twelve-month figure through Mar 2025 was $7000.0 (down 92.13% YoY), and the FY2024 annual result was $19000.0, down 81.19% from the prior year.
• Other Accumulated Expenses came in at $7000.0 for Q1 2025 at Veracyte, down from $19000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $241000.0 in Q3 2021 to a low of $7000.0 in Q1 2025.
• The 5-year median for Other Accumulated Expenses is $119000.0 (2023), against an average of $129800.0.
• Across the five-year window, Other Accumulated Expenses decreased 19.48% in 2022 and plunged 92.13% in 2025, its largest moves.
• Veracyte's Other Accumulated Expenses stood at $231000.0 in 2021, then slipped by 19.48% to $186000.0 in 2022, then tumbled by 45.7% to $101000.0 in 2023, then slumped by 81.19% to $19000.0 in 2024, then sank by 63.16% to $7000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $7000.0 (Q1 2025), $19000.0 (Q4 2024), and $53000.0 (Q3 2024), per Business Quant data.